Literature DB >> 15568158

Osteopontin expression in ductal adenocarcinomas and undifferentiated carcinomas of the pancreas.

R Sedivy1, K Peters, G Klöppel.   

Abstract

Osteopontin (OPN) is a non-collagenous extracellular matrix protein with pleiotropic functions, including mediation of cell adhesion and migration. Recently, high OPN serum levels were found in pancreatic ductal adenocarcinomas (PDACs) in which OPN mRNA was identified in macrophages. We investigated OPN expression at the protein level in 15 PDACs and 10 undifferentiated pancreatic carcinomas (UCs), 4 of them with osteoclast-like giant cells (OCGCs), to find out whether the degree of OPN expression is related to tumor infiltration by macrophages and the adhesive capacity of tumor cells. With regard to its potential adhesive function, we compared OPN expression in PDACs and UCs with that of E-cadherin and beta-catenin, two well-known adhesive molecules. OPN positivity was observed in two-thirds of PDACs (10/15) and in 7 UCs (7/10), including all 4 UCs with OCGCs. Apart from tumor cells, OPN was expressed in macrophages and OCGCs. When we assessed the relationship between the number of OPN-positive macrophages and tumor cells, we did not find any statistically significant correlation. There was also no correlation, either positive or negative, between OPN expression and E-cadherin and beta-catenin expression. The results demonstrated that, in PDACs and UCs, OPN is expressed in both tumor-associated macrophages and tumor cells. The biological significance of this dual expression pattern is not yet known. It is, however, unlikely that OPN has an adhesive function, since its expression pattern differs distinctly from that of E-cadherin or beta-catenin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15568158     DOI: 10.1007/s00428-004-1142-x

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  20 in total

1.  Giant cell tumor of the pancreas of the osteoclastic type associated with a mucous secreting cystadenocarcinoma.

Authors:  J A Posen
Journal:  Hum Pathol       Date:  1981-10       Impact factor: 3.466

2.  Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence.

Authors:  A Oldberg; A Franzén; D Heinegård
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

Review 3.  Matrix remodeling after stroke. De novo expression of matrix proteins and integrin receptors.

Authors:  J A Ellison; F C Barone; G Z Feuerstein
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

4.  Osteopontin expression and distribution in human carcinomas.

Authors:  L F Brown; A Papadopoulos-Sergiou; B Berse; E J Manseau; K Tognazzi; C A Perruzzi; H F Dvorak; D R Senger
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

Review 5.  The nature and significance of osteopontin.

Authors:  W T Butler
Journal:  Connect Tissue Res       Date:  1989       Impact factor: 3.417

Review 6.  Osteopontin: a protein with diverse functions.

Authors:  D T Denhardt; X Guo
Journal:  FASEB J       Date:  1993-12       Impact factor: 5.191

7.  Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques.

Authors:  E R O'Brien; M R Garvin; D K Stewart; T Hinohara; J B Simpson; S M Schwartz; C M Giachelli
Journal:  Arterioscler Thromb       Date:  1994-10

Review 8.  Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1/osteopontin gene.

Authors:  R Patarca; R A Saavedra; H Cantor
Journal:  Crit Rev Immunol       Date:  1993       Impact factor: 2.214

9.  Expression of osteopontin in a macrophage cell line and in transgenic mice with pulmonary fibrosis resulting from the lung expression of a tumor necrosis factor-alpha transgene.

Authors:  Y Miyazaki; T Tashiro; Y Higuchi; M Setoguchi; S Yamamoto; H Nagai; M Nasu; P Vassalli
Journal:  Ann N Y Acad Sci       Date:  1995-04-21       Impact factor: 5.691

Review 10.  What is the origin of pancreatic adenocarcinoma?

Authors:  Parviz M Pour; Krishan K Pandey; Surinder K Batra
Journal:  Mol Cancer       Date:  2003-01-22       Impact factor: 27.401

View more
  10 in total

1.  Matricellular proteins osteopontin and osteonectin/SPARC in pancreatic carcinoma.

Authors:  Anne M Delany
Journal:  Cancer Biol Ther       Date:  2010-07-01       Impact factor: 4.742

Review 2.  SIBLINGs and SPARC families: their emerging roles in pancreatic cancer.

Authors:  Ferda Kaleağasıoğlu; Martin R Berger
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 3.  Osteopontin is a promoter for hepatocellular carcinoma metastasis: a summary of 10 years of studies.

Authors:  Lunxiu Qin
Journal:  Front Med       Date:  2014-01-25       Impact factor: 4.592

4.  Genomic aberrations in hepatocellular carcinoma related to osteopontin expression detected by array-CGH.

Authors:  Jin-Cai Wu; Bing-Sheng Sun; Ning Ren; Qing-Hai Ye; Lun-Xiu Qin
Journal:  J Cancer Res Clin Oncol       Date:  2009-10-16       Impact factor: 4.553

5.  Osteopontin splice variant as a potential marker for metastatic disease in pancreatic adenocarcinoma.

Authors:  Ali A Siddiqui; Elizabeth Jones; Darren Andrade; Apeksha Shah; Thomas E Kowalski; David E Loren; Galina Chipitsyna; Hwyda A Arafat
Journal:  J Gastroenterol Hepatol       Date:  2014-06       Impact factor: 4.029

6.  Induction of osteopontin expression by nicotine and cigarette smoke in the pancreas and pancreatic ductal adenocarcinoma cells.

Authors:  Galina Chipitsyna; Qiaoke Gong; Rathai Anandanadesan; Amer Alnajar; Surinder K Batra; Uwe A Wittel; Diane M Cullen; Mohammed P Akhter; David T Denhardt; Charles J Yeo; Hwyda A Arafat
Journal:  Int J Cancer       Date:  2009-07-15       Impact factor: 7.396

7.  Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer.

Authors:  Jordan M Winter; Angela H Ting; Felip Vilardell; Eike Gallmeier; Steve B Baylin; Ralph H Hruban; Scott E Kern; Christine A Iacobuzio-Donahue
Journal:  Clin Cancer Res       Date:  2008-01-15       Impact factor: 12.531

Review 8.  Stromal Protein-Mediated Immune Regulation in Digestive Cancers.

Authors:  Pia Gamradt; Christelle De La Fouchardière; Ana Hennino
Journal:  Cancers (Basel)       Date:  2021-01-05       Impact factor: 6.639

9.  Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.

Authors:  Bhavik Desai; Michael J Rogers; Meenakshi A Chellaiah
Journal:  Mol Cancer       Date:  2007-03-07       Impact factor: 27.401

10.  Long-term survivor of a resected undifferentiated pancreatic carcinoma with osteoclast-like giant cells who underwent a second curative resection: A case report and review of the literature.

Authors:  Shinjiro Kobayashi; Hiroshi Nakano; Nobuyuki Ooike; Masaki Oohashi; Satoshi Koizumi; Takehito Otsubo
Journal:  Oncol Lett       Date:  2014-07-08       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.